13 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $5.8B | -$386M | 15.5% | 0.0% | $51M | $4.1B | $670M |
| 2024 | $5.8B | $69M | 19.8% | 0.0% | -$993M | $4.1B | $713M |
| 2023 | $6.1B | -$253M | 21.4% | 0.0% | $186M | $4.0B | $1.2B |
| 2022 | $6.8B | $578M | 23.7% | 0.0% | $448M | $3.6B | $1.1B |
| 2021 | $6.3B | $608M | 21.8% | 0.0% | $537M | $3.7B | $1.5B |
| 2020 | $5.0B | $219M | 21.5% | 0.0% | $540M | $4.0B | $1.1B |
| 2019 | $5.5B | -$52M | 19.2% | 0.0% | $169M | $4.0B | $943M |
| 2018 | $6.6B | $995M | 29.7% | 0.0% | $642M | $4.0B | $1.2B |
| 2017 | $6.2B | $746M | 28.2% | 0.0% | $229M | $4.1B | $1.6B |
| 2016 | $5.4B | $7M | 20.4% | 0.0% | $256M | $3.6B | $902M |
| 2015 | — | -$90M | — | — | -$337M | $4.0B | $366M |
| 2014 | — | $400M | — | — | -$99M | $0 | $0 |
| 2013 | — | $423M | — | — | $360M | — | $0 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1.4B | -$29M | 15.4% | 0.0% | -$93M | $4.1B | $563M |
| Dec '25 | $1.3B | -$47M | 11.7% | 0.0% | $92M | $4.1B | $670M |
| Sep '25 | $1.5B | $46M | 15.6% | 0.0% | $105M | $4.1B | $613M |
| Jun '25 | $1.6B | -$380M | 17.2% | 0.0% | $50M | $4.1B | $502M |
| Mar '25 | $1.4B | -$5M | 17.3% | 0.0% | -$196M | $4.1B | $464M |
| Dec '24 | $1.4B | -$11M | 19.5% | 0.0% | $29M | $4.1B | $713M |
| Sep '24 | $1.5B | -$32M | 19.0% | 0.0% | $63M | $4.0B | $596M |
| Jun '24 | $1.6B | $60M | 19.8% | 0.0% | -$693M | $4.0B | $604M |
| Mar '24 | $1.4B | $54M | 20.9% | 0.0% | -$392M | $4.0B | $746M |
| Dec '23 | $1.4B | -$18M | 18.6% | 0.0% | $347M | $4.0B | $1.2B |
| Sep '23 | $1.5B | $12M | 18.2% | 0.0% | $45M | $3.9B | $852M |
| Jun '23 | $1.7B | -$376M | 24.7% | 0.0% | $9M | $3.6B | $738M |
| Mar '23 | $1.5B | $145M | 24.0% | 0.0% | -$215M | $3.6B | $816M |
| Dec '22 | $1.3B | -$97M | 15.1% | 0.0% | $94M | $3.6B | $1.1B |
| Sep '22 | $1.8B | $240M | 24.3% | 0.0% | $229M | $3.5B | $1.2B |
| Jun '22 | $1.9B | $201M | 26.0% | 0.0% | $229M | $3.7B | $1.2B |
| Mar '22 | $1.8B | $234M | 27.6% | 0.0% | -$104M | $3.7B | $1.1B |
| Dec '21 | $1.6B | $233M | 25.0% | 0.0% | $131M | $3.7B | $1.5B |
| Sep '21 | $1.7B | $214M | 25.4% | 0.0% | $244M | $3.8B | $1.0B |
| Jun '21 | $1.7B | $66M | 16.0% | 0.0% | $189M | $4.0B | $1.1B |
How the market has priced CC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Chemours Co's revenue has grown 3.2% per year. These are computed facts, not advice.
As of FY2025, Chemours Co reported $4.1B of total debt against $670M of cash.
In FY2025, gross margin was 15.5%, operating margin —, and net margin -6.6%.
As of Jun '26, Chemours Co traded at a price-to-earnings ratio of about 27.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.